Resona Asset Management Co. Ltd. Purchases Shares of 60,003 The Cooper Companies, Inc. (NASDAQ:COO)

Resona Asset Management Co. Ltd. acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 60,003 shares of the medical device company's stock, valued at approximately $5,520,000.

Several other large investors also recently modified their holdings of the business. Fulton Bank N.A. boosted its stake in Cooper Companies by 3.0% during the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after acquiring an additional 109 shares during the last quarter. Torray Investment Partners LLC grew its stake in Cooper Companies by 0.8% in the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock worth $1,488,000 after purchasing an additional 132 shares in the last quarter. Mather Group LLC. increased its holdings in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after buying an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock valued at $93,000 after buying an additional 136 shares in the last quarter. Finally, Greenleaf Trust lifted its holdings in Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company's stock worth $268,000 after buying an additional 139 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analyst Weigh In

A number of research firms have commented on COO. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Citigroup decreased their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Finally, Robert W. Baird dropped their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Stock Up 1.0 %

COO stock traded up $0.75 during trading hours on Monday, hitting $78.21. The company's stock had a trading volume of 255,988 shares, compared to its average volume of 1,391,626. The company has a market capitalization of $15.64 billion, a PE ratio of 40.11, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The stock has a 50 day moving average price of $84.64 and a two-hundred day moving average price of $94.52. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.